What is the appropriate next management for a patient with hypotension (blood pressure 100/70 mm Hg) that does not improve after a 1‑liter normal‑saline bolus?

Initiate Vasopressor Therapy Immediately

For fluid-refractory hypotension (BP 100/70 after 1L NS bolus), you should start norepinephrine as the first-line vasopressor while simultaneously assessing the underlying shock etiology. 1

Immediate Management Algorithm

1. Start Vasopressor Without Delay

• Norepinephrine is the first-line agent for shock of uncertain etiology and has wide applicability across most shock states 1, 2
• Do not wait for central access—peripheral administration is safe and facilitates early use, which may improve outcomes 2
• Target MAP ≥65 mmHg initially, though this should be individualized based on the patient's baseline blood pressure and comorbidities 1

2. Determine Shock Type While Initiating Vasopressors

Distributive Shock (sepsis, anaphylaxis, neurogenic):

• Norepinephrine remains first-line 1
• If hypotension persists despite norepinephrine, add vasopressin (up to 0.03 units/min) to reduce norepinephrine requirements 1
• Consider dobutamine if evidence of myocardial depression with decreased perfusion 1

Cardiogenic Shock:

• If tachycardic: use norepinephrine 1
• If bradycardic: consider dopamine 1
• Inotropes (dobutamine) are first-line for acute heart failure with hypotension 1
• In afterload-dependent states (aortic/mitral stenosis): use phenylephrine or vasopressin 1

Hypovolemic Shock:

• Vasopressor use is controversial—preferred treatment is correcting volume deficit 2
• However, vasopressors can temporize while addressing the underlying cause
• Continue aggressive fluid resuscitation alongside vasopressor support

Obstructive Shock (PE, tamponade, tension pneumothorax):

• Vasopressors temporize until definitive therapy reverses the cause 2
• Norepinephrine is reasonable while arranging definitive intervention

3. Monitoring Targets Beyond MAP

Complement blood pressure targets with serial markers of perfusion 1:

• Lactate clearance (most important prognostic marker)
• Urine output (goal >0.5 mL/kg/hr)
• Mental status
• Skin perfusion and capillary refill
• Central/mixed venous oxygen saturation
• Renal and liver function

4. Practical Considerations for Vasopressor Administration

Early initiation is key:

• Vasopressors may be started during fluid resuscitation, not necessarily after completing it 1
• Early use may be beneficial across shock states 2

Peripheral vs. central access:

• Peripheral administration is safe and should not delay therapy 2
• Transition to central access when feasible for prolonged infusions

Push-dose vasopressors:

• Consider push-dose vasopressin (1 unit IV) for immediate temporizing in severe hypotension while preparing continuous infusion 3
• Effect lasts approximately 120 minutes 3

Common Pitfalls to Avoid

1. Delaying vasopressors while pursuing additional fluid boluses when the patient is already fluid-refractory—this worsens organ hypoperfusion
2. Waiting for central access before starting vasopressors—peripheral administration is safe and delays worsen outcomes
3. Using dopamine as first-line—only recommended in hypotensive patients with bradycardia or low tachycardia risk 1
4. Ignoring physiologic factors that impair vasopressor effectiveness: acidosis, adrenal insufficiency, hypothermia 2
5. Focusing solely on MAP without assessing end-organ perfusion markers like lactate and urine output 1

Refractory Hypotension Considerations

If hypotension persists despite norepinephrine:

• Add vasopressin (up to 0.03 units/min) 1, 4
• Consider hydrocortisone if adrenal insufficiency suspected 2
• Reassess for missed diagnoses (occult bleeding, cardiac tamponade, adrenal crisis)
• Evaluate acid-base status and correct severe acidosis 2

Titrate vasopressors to effect, not to fixed doses, using continuous arterial blood pressure monitoring when possible 1.